GM2 Gangliosidosis drugs are in phase 1 which will boost the market during the forecast period

Iiishika28 Jun, 2023Health

GM2 Gangliosidosis, often known as Tay-Sachs disease, is caused by a mutation in the HEXA genes, which results in muscular atrophy. Because this disease has no known cure, therapy is mainly symptom-based. Some of the signs and symptoms include exaggerated reactions to loud noises, seizures, loss of movement, vision, and hearing, mucus collection in the lungs, and other symptoms. Tay-Sachs disease is also known as hexosaminidase disease. A deficiency is a rare inherited neurological disease caused by a loss of the enzyme hexosaminidase A, which results in the accumulation of G2 gangliosides.